Quick Takeaways
- Norwest Venture Partners XVI, LP filed SCHEDULE 13D/A for MBX BIOSCIENCES, INC. Common Stock, $0.0001 par value per share (MBX).
- Disclosed ownership: 4.8%.
- Date of event: 26 Sep 2025.
Quoteable Key Fact
"Norwest Venture Partners XVI, LP disclosed 4.8% ownership in MBX BIOSCIENCES, INC. Common Stock, $0.0001 par value per share (MBX) on 26 Sep 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Norwest Venture Partners XVI, LP | 4.8% | 2,136,335 | 0 | 2,136,335 | /s/ Matthew De Dominicis | By Genesis VC Partners XVI, LLC, its General Partner, By NVP Associates, LLC, its Managing Member, By Matthew De Dominicis, Chief Financial Officer | 0001876200 |
| Genesis VC Partners XVI, LLC | 4.8% | 2,136,335 | 0 | 2,136,335 | /s/ Matthew De Dominicis | By NVP Associates, LLC, its Managing Member, By Matthew De Dominicis, Chief Financial Officer | |
| NVP Associates, LLC | 4.8% | 2,136,335 | 0 | 2,136,335 | /s/ Matthew De Dominicis | By Matthew De Dominicis, Chief Financial Officer | 0001545692 |
| Jeffrey Crowe | 4.8% | 2,136,335 | 0 | 2,136,335 | /s/ Matthew De Dominicis | By Matthew De Dominicis, Attorney-in-fact | 0001535261 |
| Jon Erik Kossow | 4.8% | 2,136,335 | 0 | 2,136,335 | /s/ Matthew De Dominicis | By Matthew De Dominicis, Attorney-in-fact | 0001726084 |
| Tiba Aynechi | 4.8% | 2,140,989 | 4,654 | 2,136,335 | /s/ Matthew De Dominicis | By Matthew De Dominicis, Attorney-in-fact | 0001669220 |